Evidence map›Paper›PMID 38123598›Full record

ArticleScientific data2023

T1DiabetesGranada: a longitudinal multi-modal dataset of type 1 diabetes mellitus.

Ciro Rodriguez-Leon, Maria Dolores Aviles-Perez, Oresti Banos, Miguel Quesada-Charneco, Pablo J Lopez-Ibarra Lozano, Claudia Villalonga, Manuel Munoz-Torres

Abstract readDataset
In one paragraph

Article in Scientific data, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ciro Rodriguez-LeonUniversity of Granada, Research Center for Information and Communication Technologies, Granada, 18014, Spain. crleon@correo.ugr.es.ORCID 0000-0002-3920-7207
Maria Dolores Aviles-PerezUniversity Hospital Clínico San Cecilio, Endocrinology and Nutrition Unit, 18016, Granada, Spain.
Oresti BanosUniversity of Granada, Research Center for Information and Communication Technologies, Granada, 18014, Spain.ORCID 0000-0001-5434-4253
Miguel Quesada-CharnecoUniversity Hospital Clínico San Cecilio, Endocrinology and Nutrition Unit, 18016, Granada, Spain.
Pablo J Lopez-Ibarra LozanoUniversity Hospital Clínico San Cecilio, Endocrinology and Nutrition Unit, 18016, Granada, Spain.
Claudia VillalongaUniversity of Granada, Research Center for Information and Communication Technologies, Granada, 18014, Spain.ORCID 0000-0003-4253-7909
Manuel Munoz-TorresUniversity Hospital Clínico San Cecilio, Endocrinology and Nutrition Unit, 18016, Granada, Spain. mmt@ugr.es.

Funding

Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI18-01235
6 · The paper itself

Abstract

Type 1 diabetes mellitus (T1D) patients face daily difficulties in keeping their blood glucose levels within appropriate ranges. Several techniques and devices, such as flash glucose meters, have been developed to help T1D patients improve their quality of life. Most recently, the data collected via these devices is being used to train advanced artificial intelligence models to characterize the evolution of the disease and support its management. Data scarcity is the main challenge for generating these models, as most works use private or artificially generated datasets. For this reason, this work presents T1DiabetesGranada, an open under specific permission longitudinal dataset that not only provides continuous glucose levels, but also patient demographic and clinical information. The dataset includes 257 780 days of measurements spanning four years from 736 T1D patients from the province of Granada, Spain. This dataset advances beyond the state of the art as one the longest and largest open datasets of continuous glucose measurements, thus boosting the development of new artificial intelligence models for glucose level characterization and prediction.

Indexed as

Diabetes Mellitus, Type 1Artificial IntelligenceBlood GlucoseBlood Glucose Self-MonitoringGlucoseHumansQuality of LifeBlood GlucoseGlucose

Identifiers

PMID38123598
PMCPMC10733323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.